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Purpose: The purpose of this study was to develop, build, and implement a virtual platform 
equipped with practical tools, relevant contents, and communication rooms, with the aim of 
facilitating patients’ self-management of type 1 diabetes mellitus (T1DM).
Materials and methods: The design of the platform was based on the suggestions of T1DM 
patients who were being managed at two reference hospitals. Patients’ needs and preferences 
were identified in group discussion sessions. Before having access to the platform, patients 
underwent a baseline assessment, which included physical examination and the administration 
of validated questionnaires for evaluation of clinical background, quality of life, treatment 
satisfaction, and well-being.
Results: A total of 33 patients were included in the study; 54.5% of them were men, their median 
age was 34 (18–50) years, the median duration of diabetes was 15 (1–38) years, and the median 
A1C was 7.4% (6%–12.6%). Based on their suggestions and requests, the online platform EncoDiab 
was built and organized into four domains: a personal domain, two domains shared by the patients 
and the staff of each of the two participating hospitals, and one domain that was accessible to all 
participants. The platform included practical tools (a body mass index calculator, a carbohydrate 
counting tool, and an insulin-dose calculator), a library with relevant information (documents on 
prevention and treatment of acute complications, nutrition, exercise, etc), and a chat room.
Conclusion: Although the study is still ongoing, our current results demonstrate the feasibil-
ity of building and implementing an online platform for helping T1DM patients in the self-
management of their disease in the public health setting.
Keywords: eHealth, behavioral health, telehealth, education
Introduction
Tight glycemic control in type 1 diabetes mellitus (T1DM) reduces the risk of 
developing chronic complications of the disease.1 However, barriers preventing 
glycemic improvement can be found in the patient, in health care professionals, in the 
disease itself, and in the organization of health care services.2,3 Indeed, the daily man-
agement of the disease usually falls on the patient. Although providing an environment 
that facilitates diabetes self-management and allows for informed decision making is 
a challenge, it may contribute to improve the management of T1DM.4
Comanagement of this disease has already proved feasible.5,6 The aim of the present 
project was to shift the task of disease management and responsibility from health care 
professionals to patients themselves by providing high-quality resources to support 
them in self-management and informed decision making.
The incorporation of the Internet into our daily life has transformed the relation-
ship between patients and health care professionals.7 Nowadays, “the web” is the most 
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frequently consulted source of information on diseases. 
 Nevertheless, the reliability of certain content is uncertain, and 
myths and lies are also spread efficiently.7 In the context of 
a reliable virtual environment, accurate information can be a 
powerful tool to support patients’ self-management of this dis-
ease, without the time and space limits of other resources.
New technologies can be used by health care professionals 
to assist patients in the management of diabetes. Actually, ran-
domized controlled trials have shown that web-based support 
may have a positive impact on the process and quality of dia-
betes care, quality of life, and treatment satisfaction.8–10 Virtual 
interaction among patients with the same disease has not been 
rigorously assessed, but reports on discussion groups, chats, or 
a combination of these with news groups have been published.11 
Most of them are run and promoted by health professionals, 
who stimulate discussion, propose or answer questions, or post 
useful pieces of news. A study analyzing patients’ perspec-
tives highlighted the importance given to peer support, their 
awareness of the need to evaluate external information in each 
patient’s own context, and the value given to the experiential 
knowledge of other people with the same disease.12
The goal of this study was to design, build, and implement 
a virtual management system for patients with T1DM, in the 
public health care setting. It was conceived as a structure 
integrating information, education, assistance, and socializa-
tion. It followed the principles of the Web 2.0 philosophy, 
which enhances bidirectional communication and promotes 
adaptation of technological tools to the needs and skills of 
potential users. In the present article, we describe the design 
and implementation processes, as well as the baseline char-
acteristics of the patients included in this study. The outcome 
of the use of the platform will be reported in the future.
Materials and methods
Study population and design
Participants were recruited among T1DM patients who 
were being treated at any of the two participating hospitals 
(Complejo Hospitalari Universitario Insular Materno-Infantil 
of Gran Canaria, Las Palmas, Spain and Hospital Universitari 
Arnau de Vilanova in Lleida, Spain). Inclusion criteria were: 
patients older than 18 years, T1DM diagnosed at least 1 year 
before, Internet connection at home, basic skills in the use of 
information and communications technology, and having an 
email account. Pregnant women and people with psychiat-
ric or other conditions that could potentially interfere with 
follow-up were excluded. The study was approved by the Eth-
ics Committees of both participating hospitals. Patients were 
contacted in the outpatient clinic, where they were offered 
a brief description of the study and invited to participate. 
Interested patients were appointed for a subsequent specific 
visit, where they were given detailed oral and written infor-
mation and those wanting to participate were asked to sign an 
informed consent form. They were also asked to sign consent 
for potential promotional use of the pictures taken during 
the group sessions. Furthermore, the participants committed 
themselves to honor privacy and to act with mutual respect 
in the interactions within the platform.
In order to identify the patients’ needs and preferences, 
group sessions were organized, where participants were 
asked about the tools and contents they would like to find 
on an online platform. Indeed, one of the main goals of this 
project was that the patients themselves settled the basis for 
the design of the platform.
The 17 participants from the Complejo Hospitalario 
Universitario Insular Materno-Infantil of Gran Canaria 
were split into two groups, which took part in two parallel 
2-hour group discussion sessions. Brainstorming was used 
to identify and record all the relevant aspects suggested by 
the participants,13 which were then ordered by priority (since 
it was assumed that covering all the recorded items within 
this project would not be feasible).
Participants from the Hospital Universitario Arnau de 
Vilanova in Lleida participated in 2-hour discussion sessions 
in two groups of eight subjects each. They were asked to dis-
cuss those aspects that would improve their quality of life and 
diabetes management. A sociology PhD student, who was in 
charge of designing the virtual environment, a diabetes nurse 
specialist (from the Lleida Patients Association), and the 
engineer in charge of the final platform design were present 
in the sessions and provided advice when needed.
Patients’ needs and suggestions identified in both hospi-
tals were compiled into a common document, which was used 
as the basis for the design of the platform. The platform was 
built by using the content management system Drupal and 
adapted to the requirements of this type of system, as well 
as to those established by the patients. It was hosted on an 
independent dedicated server in compliance with the national 
regulations (law LO 15/1999 on the protection of personal 
data [LOPD] and RD 1720/2007, BOE-A-2008-979).
Patients
The initial population of the study included 33 patients (17 
from Gran Canaria and 16 from Lleida): 54.5% of them 
were men; the median age was 34 (18–50) years; they had 
a median T1DM duration of 15 (1–38) years, a median 
A1C of 7.4% (6%–12.6%), and a median body mass index 
(BMI) of 24.6 (16.4–37.7 kg/m2); and 72.7% of them were 
workers, 24.2% were students, and 3% were homemakers. 
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Table 1 shows their needs and suggestions as recorded during 
the group sessions.
Implementation and evaluation
Six months after the initial group sessions, patients were 
appointed for a baseline evaluation visit, before being given 
access to the platform. Every participant received an email with 
their individual username and password to access the platform. 
There, they would find the contents and tools they had previously 
suggested and would be able to communicate with other partici-
pants and with health care professionals at their hospital.
During the baseline evaluation visit, information was 
collected on diabetes, possible associated complications, 
cardiovascular risk factors, and other possible diseases and 
treatments. Physical examination included blood pressure, 
anthropometric measurements, and foot examination. Blood 
Table 1 Patient requests for Encodiab
Features and usability of the environment Included
It should be possible to identify whether a participant is a health care professional or a patient, even if he/she is anonymous. x
Frequent updates. P
There should be a search engine available, to find specific information. x
It should be usable with any of the standard browsers. x
It should be usable from mobile phones. P
It should be linked to social media. x
It should be possible to label contents to facilitate search. x
It should be possible to mark contents with “+1” or “I like” and to make comments so that other participants can identify  
the most popular ones.
x
Contents
Nutritional information: macronutrient composition, carbohydrate portions, pictures, recipes. x
Instructions on how to act in special situations: what to do when making a mistake in the dose of insulin. x
Information for family members, place of work, schools: how to act in acute situations (PdF for convenient printing). x
Pregnancy: therapeutic targets, pre-pregnancy follow-up, pregnancy, and chronic diabetes complications. P
traveling: medical reports needed, what to take in the hand luggage, how to transport and distribute insulin in the  
luggage, etc.
x
Advances in diabetes: research, new treatments. x
Blood glucose meters: features and performance of those available. x
Information about sweeteners. x
Information about drugs that may alter glycemic control. x
Insulin injection technique. Sites and rotation.
Information about chronic complications of diabetes. P
How to treat hypoglycemia. How to use glucagon (printable PdF). x
How to treat hyperglycemia: simple hyperglycemia, ketosis (printable PdF). x
Foot care.
legal issues related to diabetes: contracts, health and life insurance, driving license, subsidies, etc. x
Important telephone numbers: glucose meter and pump manufacturers.
Geolocalization of pharmacies with insulin available.
Information about who is the on-call endocrinologist in both hospitals.
Newsletters. Interviews with celebrities who suffer from diabetes or with other participants in the platform,  
to share experience.
library, resources, etc. links to important diabetes webpages American diabetes Association, etc. x
Applications (with instructions) and related subjects. x
Application to download information from glucose meters.
Basic formulas: insulin sensitivity factor, insulin-dose calculation based on carbohydrate intake, correction bolus  
calculation.
x
A calculator that allows computation of these formulas directly. x
Modifications of insulin dose in special situations:
• Exercise (according to the type of exercise)
• Illness and other situations (menstruation, fever, vomiting...)
• changes in daily physical activity (weekends, siesta...)
• Alcohol intake
• Barbecues and celebrations (snacking)
x
contact management. x
contact information of physicians, nurses, manufacturers (insulin, meters, technology...), health institutions, press. P
(Continued)
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samples were collected to measure A1C (high-performance 
liquid chromatography-National Glycohemoglobin Stan-
dardization Program standardized), lipids, kidney and liver 
assessment (colorimetry), thyroid-stimulating hormone 
(TSH), and albuminuria.
To evaluate quality of life and treatment satisfaction, the 
validated, Spanish versions of the following questionnaires 
were administered: Audit of Diabetes-Dependent Quality of 
Life,14 Diabetes Treatment Satisfaction Questionnaire,15 and 
12-item Well-Being Questionnaire.16 In addition, each patient 
was asked to define up to three personal goals related to the 
platform, to be assessed during the follow-up.
All of these parameters were evaluated at baseline and 
again 12 months later. In addition, participants’ activity, use 
of resources, and permanence on the platform during the 
6 months following their first access were quantified by using 
tools incorporated into the platform.
The platform EncoDiab was built progressively and did 
not include all of the patients’ suggestions from the start. At 
present, it is organized into four domains: a personal domain for 
every participant, one for interactions between the patients and 
health care professionals in Lleida, one for interactions between 
the patients and health care professionals in Gran Canaria, and 
one for general interactions among all participants.
Personal domains include: a customizable entry panel 
for profile editing, access to interactive tools (BMI calcula-
tor, glucose and insulin-dose register, carbohydrate portion 
calculator, and insulin-dose calculator), and activation of 
Table 1 (Continued)
Features and usability of the environment Included
Calendars
A public calendar with activities, congresses, social meetings....
A private calendar for every participant where all diabetes-related issues could be integrated into daily life.  
Appointments should be automatically recorded on a private calendar.
x
Personal documentation area
Access to a personal health folder (electronic record). P
Sampling.
Personal statistics with graphs.
test results.
Possibility of activating alerts for scheduled visits or prescription expiry. Identification of abnormal results,  
eg, with a different color.
Private “virtual” glucose record with links to carbohydrate portion records that can be saved and retrieved for a  
better interpretation of glucose values. Possibility to submit such data to a health care professional.
Possibility of consulting a health care professional via videoconference together with availability of editable records,  
in order to get new prescriptions if needed.
online consultation. urgent questions should be replied to within 24 hours (although it would not be possible  
to choose the health care professional). For non-urgent questions, it should be possible to choose a health care  
professional or any one that is available. In both cases, the patient should be able to decide if the consultation is  
public or private. If public, other participants (patients and health care professionals) would be able to give their  
opinion and start a discussion.
P
A notice should be sent when the consultation has been replied to. If urgent, it should be sent via SMS. the patient  
should be able to decide when the event is closed.
x
A printable calendar with scheduled appointments should be available on the platform. It should be possible to  
change the date of blood testing appointments.
Diabetes education courses/information
Food labeling (composition, carbohydrate portions...). x
Portions: description, how to adjust insulin doses to carbohydrate and fat intake. x
diet: healthy diet, losing and gaining weight. x
How to use software to download glucose meter data. x
Myths about diabetes (no sweets...). x
What is type 1 diabetes? differences with type 2 diabetes regarding treatment and pathogenesis.
Information about insulin pumps: indications, basic management. x
Chats
Interaction with other patients with the participation of health care professionals acting as moderators when necessary. x
Possibility of asking a health care professional who would reply in a reasonable time. x
Possibility of synchronous consultation. P
Mailbox for suggestions for continuous improvement of the platform. P
Information about patient associations or links to their webs (although patients do not want the associations to  
access the platform).
x
Note: The column on the right shows which suggestions have been incorporated into the platform, either as expressed by the patients (x) or somewhat modified (P).
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subscriptions to notifications. Figure 1 shows the BMI cal-
culator, a simple tool in which patients can enter their weight 
and height and get their BMI as a result. A color code shows 
whether the BMI is healthy or not (green for normal, yellow 
for overweight, and red for obesity). Figure 2 shows the 
carbohydrate portion and insulin-dose calculator and Figure 3 
shows the glucose and insulin-dose register, which can 
be submitted to a health care professional for evaluation. 
In addition, this domain includes an internal mail system 
for private one-to-one communication, a personal calendar 
Figure 1 Body mass index calculator.
Figure 2 carbohydrate portion and insulin-dose calculator.
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Figure 4 Private calendar.
Figure 3 Blood glucose register.
(Figure 4), and access to other areas the participant is allowed 
to enter.
The other domains are structured as follows: a customiz-
able entry panel, a blog, a group calendar, a list of members 
allowed interaction in the domain, and a chat room. The 
library (Figure 5) contains a folder with recent commented 
articles, a section about physical exercise (how to start an 
exercise program, recommendations for insulin-dose adjust-
ments, etc), a folder with legal information (subsidies), 
a folder with relevant health information (glucose meters, 
continuous glucose sensors, management of hypoglycemia 
and ketosis), a folder with documents on nutrition (general 
recommendations, links, food groups, healthy eating, fre-
quently asked questions, recipes), selected links, and video 
tutorials about the use of the platform.
There is also a discussion section, which was created 
with the aim of facilitating interaction among patients 
(Figure 6).
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Validation group
Upon continuation of the project, 6 months after the start 
of the use of the platform, a new group of 29 patients (who 
did not participate in the design) has been given access to 
it after a baseline evaluation equivalent to that of the first 
group. This second group will be followed for 1 year. The 
details and results of this validation process will be published 
in the future.
Amplification of EncoDiab
A few months after the validation group was given access to 
the platform, it was also opened to other adults with T1DM 
who were interested. At the time of the present report, a 
total of 175 users are members of EncoDiab. An online 
questionnaire will be used to evaluate their satisfaction with 
the platform.
Discussion
T1DM has a huge impact on the lives of people who have the 
disease. Strategies aimed at empowering patients to manage 
it independently have proved to be effective.4 EncoDiab 
offers the tools for establishing a virtual community that 
facilitates communication among patients and with health 
care professionals. It provides practical tools for daily 
diabetes management and reliable information to support 
informed decision making. Above all, it is conceived as 
a place where patients play the leading role. This type of 
platform may offer other benefits, such as reducing isola-
tion, promoting a positive psychological state, and acquiring 
healthy habits.17 Studies have shown that discussion forums 
and conversation rooms for interaction among patients who 
suffer from the same disease may have a positive effect on 
the participants, leading them to a more favorable  disposition 
Figure 5 Access to the library.
Notes: the most recent documents are visible. on the right-hand side, accessible folders containing additional documents can be seen.
Figure 6 Patient discussion room.
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to control their disease.18 The availability of a reliable set-
ting, with health professionals who offer advice and select 
and provide appropriate information, may empower patients 
to take responsibility for the control of their disease, have a 
positive effect on their level of commitment, and help them 
establish actions leading to better diabetes care.19 Other 
authors have reported the benefits of online platforms like 
EncoDiab, such as helping reduce communication barriers 
between patients and health care providers,20 which may 
eventually lead to improved self-care and self-management 
of disease.21 EncoDiab also facilitates peer support. Indeed, 
several studies have illustrated the importance of patient–
health care provider communication22,23 and peer support in 
diabetes care.24
Previous studies on the effects of mobile tools, including 
web pages – which promote self-management and communi-
cation with health professionals – on T1DM patients, reported 
either improved glycemic control25 or no additional benefit 
when compared with conventional treatment.26,27
The development of EncoDiab was based on the participa-
tion of patients from the start, which is, in our opinion, the best 
way to design a system for such a close collaboration between 
providers and users. The early involvement of the users, even 
in the design of the platform, does not guarantee its success, 
but it should improve the odds. Indeed, the requests made by 
the participants in both centers (located in different and distant 
regions) were quite similar. Therefore, it is expected that the 
design of the platform would also meet the needs of other 
users. Although the analysis of the results is still in progress, 
the evaluation of the platform by its current users (more than 
150) – only a minority being present from the start – is expected 
to provide further information about its generalizability.
Conclusion
The use of online resources for the self-management of health 
conditions is a necessity in communication and technology 
information society. Actually, self-management is being 
increasingly demanded by patients, and the public health system 
is expected to provide solutions. In T1DM in particular, self-
care is a pivotal element, which could allow patients to live with 
high levels of independence from the health care team. To our 
knowledge, there is no previous evidence in our health care sys-
tem on the feasibility, efficacy, or impact of a patient-centered, 
patient-designed online system like EncoDiab, which allows 
for comprehensive self-management of T1DM.
EncoDiab makes use of technology to complement standard 
diabetes education. Patients are provided with reliable online 
resources that can be accessed anytime from anywhere.
Since the study is ongoing, the analysis of the outcomes 
is still incomplete. The goal of this project was not focused 
on demonstrating the effectiveness of a telemedicine system, 
but on building, implementing, and evaluating a T1DM 
self-management system, based on patients’ requirements, in 
a real-world, public health care setting. Conclusions would 
be premature at this point. However, in case the goal of this 
project is finally achieved, it could lead not only to further 
optimization of T1DM self-management, but also to its 
possible application to other populations (pregnant women, 
children, and adolescents) or types of diabetes, especially 
the highly prevalent type 2 diabetes.
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